BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9568693)

  • 1. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
    Hansen T; Echwald SM; Hansen L; Møller AM; Almind K; Clausen JO; Urhammer SA; Inoue H; Ferrer J; Bryan J; Aguilar-Bryan L; Permutt MA; Pedersen O
    Diabetes; 1998 Apr; 47(4):598-605. PubMed ID: 9568693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
    Rissanen J; Markkanen A; Kärkkäinen P; Pihlajamäki J; Kekäläinen P; Mykkänen L; Kuusisto J; Karhapää P; Niskanen L; Laakso M
    Diabetes Care; 2000 Jan; 23(1):70-3. PubMed ID: 10857971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.
    Inoue H; Ferrer J; Welling CM; Elbein SC; Hoffman M; Mayorga R; Warren-Perry M; Zhang Y; Millns H; Turner R; Province M; Bryan J; Permutt MA; Aguilar-Bryan L
    Diabetes; 1996 Jun; 45(6):825-31. PubMed ID: 8635661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus.
    Hart LM; Dekker JM; van Haeften TW; Ruige JB; Stehouwer CD; Erkelens DW; Heine RJ; Maassen JA
    Diabetologia; 2000 Apr; 43(4):515-9. PubMed ID: 10819247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus.
    Hansen T; Ambye L; Grarup N; Hansen L; Echwald SM; Ferrer J; Pedersen O
    Diabetologia; 2001 Oct; 44(10):1330-4. PubMed ID: 11692183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic variation in exon 18 of the sulfonylurea receptor 1 (SUR1) gene, insulin secretion and insulin sensitivity in nondiabetic relatives of type 2 diabetic subjects.
    Reis AF; Hani EH; Beressi N; Robert JJ; Bresson JL; Froguel P; Velho G
    Diabetes Metab; 2002 Jun; 28(3):209-15. PubMed ID: 12149601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM.
    Ohta Y; Tanizawa Y; Inoue H; Hosaka T; Ueda K; Matsutani A; Repunte VP; Yamada M; Kurachi Y; Bryan J; Aguilar-Bryan L; Permutt MA; Oka Y
    Diabetes; 1998 Mar; 47(3):476-81. PubMed ID: 9519757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.
    Meirhaeghe A; Helbecque N; Cottel D; Arveiler D; Ruidavets JB; Haas B; Ferrières J; Tauber JP; Bingham A; Amouyel P
    Am J Med Genet; 2001 Jun; 101(1):4-8. PubMed ID: 11343328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM.
    Hansen L; Echwald SM; Hansen T; Urhammer SA; Clausen JO; Pedersen O
    Diabetes; 1997 Mar; 46(3):508-12. PubMed ID: 9032110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
    Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
    Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM.
    Inoue H; Ferrer J; Warren-Perry M; Zhang Y; Millns H; Turner RC; Elbein SC; Hampe CL; Suarez BK; Inagaki N; Seino S; Permutt MA
    Diabetes; 1997 Mar; 46(3):502-7. PubMed ID: 9032109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with Type II diabetes mellitus in Dutch Caucasians.
    Hart LM; de Knijff P; Dekker JM; Stolk RP; Nijpels G; van der Does FE; Ruige JB; Grobbee DE; Heine RJ; Maassen JA
    Diabetologia; 1999 May; 42(5):617-20. PubMed ID: 10333056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonylurea receptor gene 16-3 polymorphism - association with sulfonylurea or insulin treatment in type 2 diabetic subjects.
    Zychma MJ; Gumprecht J; Strojek K; Grzeszczak W; Moczulski D; Trautsolt W; Karasek D
    Med Sci Monit; 2002 Jul; 8(7):CR512-5. PubMed ID: 12118200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased fasting and oral glucose stimulated C-peptide in nondiabetic subjects with sequence variants in the sulfonylurea receptor 1 gene.
    Weisnagel SJ; Rankinen T; Nadeau A; Rao DC; Chagnon YC; Pérusse L; Bouchard C
    Diabetes; 2001 Mar; 50(3):697-702. PubMed ID: 11246895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
    Gloyn AL; Hashim Y; Ashcroft SJ; Ashfield R; Wiltshire S; Turner RC;
    Diabet Med; 2001 Mar; 18(3):206-12. PubMed ID: 11318841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians.
    Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
    Hum Genet; 2000 Aug; 107(2):138-44. PubMed ID: 11030411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians.
    Hani EH; Clément K; Velho G; Vionnet N; Hager J; Philippi A; Dina C; Inoue H; Permutt MA; Basdevant A; North M; Demenais F; Guy-Grand B; Froguel P
    Diabetes; 1997 Apr; 46(4):688-94. PubMed ID: 9075812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterization of polymorphisms in the sulphonylurea receptor 1 gene in Japanese subjects with Type 2 diabetes mellitus.
    Ishiyama-Shigemoto S; Yamada K; Yuan X; Koyama W; Nonaka K
    Diabet Med; 1998 Oct; 15(10):826-9. PubMed ID: 9796882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.
    Gloyn AL; Weedon MN; Owen KR; Turner MJ; Knight BA; Hitman G; Walker M; Levy JC; Sampson M; Halford S; McCarthy MI; Hattersley AT; Frayling TM
    Diabetes; 2003 Feb; 52(2):568-72. PubMed ID: 12540637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.